Q63L (p.Gln63Leu) variant of SOS1 (Son of sevenless homolog 1)

Q63L (p.Gln63Leu) in SOS1 (Son of sevenless homolog 1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of RASopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data and structural context.

Q63L (p.Gln63Leu) variant details